Singapore-based deep tech investor Vickers Venture Partners’s first $120 million special purpose acquisition company (SPAC), Vickers Vantage Corp I, is merging with Scilex Holding Company, a biopharmaceutical firm developing non-opioid therapies for patients.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
